Open Access

Dual anti platelet therapy duration? Very short or very long?

Seminar Presentation

About the speaker

Professor Jurrien M ten Berg

St Antonius Hospital, Nieuwegein (Netherlands (The))
17 presentations
1 follower

4 more presentations in this session

Welcome & Introduction .

Speaker: Doctor G. Vilahur (Barcelona, ES)


De-escalation of monotherapy with P2Y12 inhibitor. An alternative approach.

Speaker: Doctor J. Ferreiro (Hospitalet De Llobregat, ES)


Very low dose of rivaroxaban. It is time for a new era.

Speaker: Professor J. Morais (Leiria, PT)


The bleeding risk the true game changer.

Speaker: Professor T. Geisler (Tuebingen, DE)


Access the full session

Welcome and Session 1: From ACS to chronic coronary artery disease. The transition period

Speakers: Professor J. ten Berg, Doctor G. Vilahur, Doctor J. Ferreiro, Professor J. Morais, Professor T. Geisler

About the event


Hot topics and new insights for Thrombosis 2022

17 March 2022 17:00 CET

Related content

ACVC Premium Access

Optimal management of acute right ventricular failure: know it to treat it - discussion.

18 March 2022

ESC Premium Access

The collateral damage of COVID-19 on CVD – discussion.

27 August 2021

ESC Premium Access

COVID-19 and the risk of thrombosis.

27 August 2021

ESC 365 is supported by

logo Novo Nordisk